GLMD·M47238148·US·Common Stock·Healthcare - Biotechnology-13D/G
GLMD (GALMED PHARMACEUTICALS LTD) is held by 11 institutional investors as of Q1 2026. Largest holders: TWO SIGMA INVESTMENTS, LP ($39,287), XTX Topco Ltd ($10,822), JANE STREET GROUP, LLC ($8,058). Net institutional sentiment: Mixed.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer